Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: No relation to apolipoprotein E expression or genotype

Biological Psychiatry

Volumn 54, Issue 2, 2003, Pages 136-141

  Thomas, Elizabeth A ^a   Laws, Simon M ^b,c   Sutcliffe, J Gregor ^a   Harper, Clive ^d   Dean, Brian ^e   McClean, Catriona ^e   Masters, Colin ^e   Lautenschlager, Nicola ^c   Gandy, Samuel E ^f   Martins, Ralph N ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b HOLLYWOOD PRIVATE HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f Farber Inst Neurosci Thomas J   (United States)

Author keywords

Allele; Alzheimer's disease; Apolipoprotein; Cognitive; Enzyme linked immunosorbent assay; Prefrontal cortex

Indexed keywords

APOLIPOPROTEIN D; APOLIPOPROTEIN E;

ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN LEVEL; CORRELATION ANALYSIS; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMAN; HUMAN TISSUE; INHERITANCE; PATHOGENESIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0038784889     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01976-5     Document Type: Article

References (35)

1. Assal F., Cummings J.L. Neuropsychiatric symptoms in the dementias. Curr Opin Neurol. 15:2002;445-450.
2. Belloir B., Kovari E., Surini-Demiri M., Savioz A. Altered apolipoprotein D expression in the brain of patients with Alzheimer disease. J Neurosci Res. 64:2001;61-69.
3. Bouras C., Hof P.R., Morrison J.H. Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes. Neurosci Lett. 153:1993;131-135.
4. Braak H., Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging. 16:1995;271-278.
5. Braak H., Braak E., Bohl J., Bratzke H. Evolution of Alzheimer's disease related cortical lesions. J Neural Transm Suppl. 54:1998;97-106.
6. Calero M., Rostagno A., Matsubara E., Zlokovic B., Frangione B., Ghiso J. Apolipoprotein J (clusterin) and Alzheimer's disease. Microsc Res Tech. 50:2000;305-315.
7. Choi-Miura N.H., Oda T. Relationship between multifunctional protein "clusterin" and Alzheimer disease. Neurobiol Aging. 17:1996;717-722.
8. Chung J.A., Cummings J.L. Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease Characteristics and treatment . Neurol Clin. 18:2000;829-846.
9. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
10. Cummings J.L. Cognitive and behavioral heterogeneity in Alzheimer's disease Seeking the neurobiological basis . Neurobiol Aging. 21:2000;845-861.
11. Goldman-Rakic P.S., Selemon L.D. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr Bull. 23:1997;437-458.
12. Harr S.D., Uint L., Hollister R., Hyman B.T., Mendez A.J. Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease. J Neurochem. 66:1996;2429-2435.
13. Hof P.R., Bouras C., Perl D.P., Sparks D.L., Mehta N., Morrison J.H. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. Arch Neurol. 52:1995;379-391.
14. Kalman J., McConathy W., Araoz C., Kasa P., Lacko A. Apolipoprotein D in the aging brain and in Alzheimer's dementia. Neurol Res. 22:2000;330-336.
15. Laws S.M., Hone E., Taddei K., Harper C., Dean B., McClean C., et al. Variation at the APOE-491 promoter locus is associated with altered brain levels of apolipoprotein E. Mol Psychiatry. 7:2002;886-890.
16. Laws S.M., Taddei K., Martins G., Paton A., Fisher C., Clarnette R., et al. The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease. Neuroreport. 10:1999;879-882.
17. Lidstrom A.M., Bogdanovic N., Hesse C., Volkman I., Davidsson P., Blennow K. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease. Exp Neurol. 154:1998;511-521.
18. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease . Neurology. 34:1984;939-944.
19. Miyata M., Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet. 14:1996;55-61.
20. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:1991;163-166.
21. Poirier J. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism. Ann N Y Acad Sci. 924:2000;81-90.
22. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 342:1993;697-699.
23. Rebeck G.W., Reiter J.S., Strickland D.K., Hyman B.T. Apolipoprotein E in sporadic Alzheimer's disease Allelic variation and receptor interactions . Neuron. 11:1993;575-580.
24. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease . Proc Natl Acad Sci U S A. 90:1993;1977-1981.
25. Tanzi R.E., Bertram L. New frontiers in Alzheimer's disease genetics. Neuron. 32:2001;181-184.
26. Terrisse L., Poirier J., Bertrand P., Merched A., Visvikis S., Siest G., et al. Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. J Neurochem. 71:1998;1643-1650.
27. Thomas E.A., Dean B., Pavey G., Sutcliffe J.G. Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects Implications for the pathophysiology of psychiatric disorders . Proc Natl Acad Sci U S A. 98:2001;4066-4071.
28. Thomas EA, Dean B, Scarr E, Copolov D, Sutcliffe JG (2003): Differences in neuroanatomical sites of ApoD elevation discriminate schizophrenia and bipolar disorder. Mol Psychiatry, 8:168-176.
29. Thomas E.A., Sautkulis L.N., Criado J.R., Games D., Sutcliffe J.G. Apolipoprotein D mRNA expression is elevated in PDAPP transgenic mice. J Neurochem. 79:2001;1059-1064.
30. Tomiyama T., Corder E.H., Mori H. Molecular pathogenesis of apolipoprotein E-mediated amyloidosis in late-onset Alzheimer's disease. Cell Mol Life Sci. 56:1999;268-279.
31. Yamada T., Kondo A., Takamatsu J., Tateishi J., Goto I. Apolipoprotein E mRNA in the brains of patients with Alzheimer's disease. J Neurol Sci. 129:1995;56-61.
32. Yamagata K., Urakami K., Ikeda K., Ji Y., Adachi Y., Arai H., et al. High expression of apolipoprotein E mRNA in the brains with sporadic Alzheimer's disease. Dement Geriatr Cogn Disord. 12:2001;57-62.
33. Yang D.S., Small D.H., Seydel U., Smith J.D., Hallmayer J., Gandy S.E., Martins R.N. Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner. Neuroscience. 90:1999;1217-1226.
34. Yang D.S., Smith J.D., Zhou Z., Gandy S.E., Martins R.N. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma. J Neurochem. 68:1997;721-725.
35. Zannis V.I., Just P.W., Breslow J.L. Human apolipoprotein E isoprotein subclasses are genetically determined. Am J Hum Genet. 33:1981;11-24.